Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gaylord Container Corporation was a major industrial manufacturer that played a pivotal role in the life sciences through its specialty chemicals division, now known as Gaylord Chemical. The company is the world's leading producer of Dimethyl Sulfoxide (DMSO), a high-purity solvent and excipient essential for pharmaceutical manufacturing and drug delivery. In biotechnology, Gaylord's DMSO is the industry standard for the cryopreservation of human cells, tissues, and organs, including stem cell and CAR-T therapies. Beyond its chemical operations, the company was a significant producer of containerboard and corrugated packaging before its acquisition by Temple-Inland in 2002. Today, its legacy continues through the high-grade chemical products used across the global healthcare and research sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gaylord Container.